- Home
- World
- News
- China's COVID-19 Vaccine Trial Volunteers Have High Antibodies 6 Months After Inoculation
China's COVID-19 Vaccine Trial Volunteers Have High Antibodies 6 Months After Inoculation
Mohammad Ali (@ChaudhryMAli88) Published September 25, 2020 | 06:55 PM
Participants in China's COVID-19 vaccine clinical trials retain a relatively high level of antibodies six months after inoculation, Zeng Guang, a leading epidemiologist at the Chinese Center for Disease Control and Prevention, said on Friday
BEIJING (UrduPoint News / Sputnik - 25th September, 2020) Participants in China's COVID-19 vaccine clinical trials retain a relatively high level of antibodies six months after inoculation, Zeng Guang, a leading epidemiologist at the Chinese Center for Disease Control and Prevention, said on Friday.
China approved clinical trials of its first coronavirus vaccine on March 16. The vaccine was developed by a team led by Chen Wei, an academician of the academy of Military Medical Sciences, which headed to Wuhan in January to start research.
"At present, there are already relatively positive results, and serological tests show that the level of antibodies in the very first participants in clinical trials of the COVID-19 vaccine in our country is still quite high," Zeng said at a briefing.
According to the researcher, "this indicates that the vaccine may have a fairly long protection period.
"
He at the same time noted that long-term research is needed to determine exactly how long each of the vaccines could protect a person from the virus.
China is currently conducting clinical trials for 11 coronavirus vaccines, four of which are in phase 3, the Health Ministry reported last week.
Wang Junzhi, a member of the Chinese Academy of Engineering, said on Friday that the phase 1 and 2 trials have mainly detected minor and admissible side effects.
"Based on the currently available data, there are no signs of antibody-dependent enhancement of the infection as a result of vaccination against COVID-19," Wang said.
Antibody-dependent enhancement is a phenomenon when antibodies aid entry of the virus into host cells, leading to virus replication.
Recent Stories
Robinson, bowlers help New Zealand go 2-1 up against Pakistan
Shahzeb Chachar to hold khuli kachehri on April 26
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
Tourism must change, mayor says as Venice launches entry fee
Court adjourns Judicial Complex attack case till May 17
Nasreen Noori’s book ‘Popatan Jahra Khwab’ launched
Wafaqi Mohtasib inspection team visits Excise and taxation office
AJLAC announces 5th Conference titled ‘People’s Mandate: Safeguarding Civil ..
Pak-US officials engage to enhance trade, investment ties
IBCC to promote educational excellence, expand regional presence
Pakistani 'Blue Helmets' serving UN Peacekeeping Mission in DR Congo set to leav ..
Putin says plans to visit China in May
More Stories From World
-
Bagnaia and Spanish rivals chase victory at Jerez
46 minutes ago -
Russian, Ukrainian strikes kill at least 10 in frontline regions
56 minutes ago -
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
1 hour ago -
Tourism must change, mayor says as Venice launches entry fee
1 hour ago -
Pakistani 'Blue Helmets' serving UN Peacekeeping Mission in DR Congo set to leave after 20 years of ..
2 hours ago -
Putin says plans to visit China in May
2 hours ago
-
US reinstates open internet rules rescinded under Trump
2 hours ago -
Honda announces US$11 bn EV battery and vehicle plant in Canada
2 hours ago -
Portugal marks 50 years of democracy with far right on the rise
2 hours ago -
Oman, UAE deluge 'most likely' linked to climate change: scientists
3 hours ago -
BHP launches $38.8 billion takeover bid for rival Anglo American
3 hours ago -
Saudi oil giant Aramco agrees major FIFA sponsorship deal
3 hours ago